The effect of rutin‐N‐mustard on the survival of NK/Ly ascites tumour‐bearing mice
暂无分享,去创建一个
[1] R. Auerbach,et al. Regional differences in the growth of tumor cells injected intraperitoneally into syngeneic adult mice. , 1980, Cancer research.
[2] P. S. Dietrich,et al. Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. , 1979, Mutation research.
[3] M. Galin,et al. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas. , 1979, Cancer research.
[4] L. Bjeldanes,et al. Mutagenic activity of quercetin and related compounds. , 1977, Science.
[5] W. Whitmore,et al. Therapeutic trial of aniline mustard in patients with advanced cancer. Comparison of therapeutic response with cytochemical assessment of tumor cell β‐glucuronidase activity , 1976, Cancer.
[6] E. Racker,et al. The effect of flavonoids on aerobic glycolysis and growth of tumor cells. , 1975, Cancer research.
[7] E. Racker,et al. Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles. , 1974, Biochimica et biophysica acta.
[8] E. McCulloch,et al. Studies of nitrogen mustard transport by mouse myeloma and hemopoietic precursor cells. , 1973, Cancer research.
[9] Y. Hashimoto,et al. Increased immunosensitivity in nitrogen mastard-resistant Yoshida sarcoma. , 1973, Cancer research.
[10] G. Goldenberg,et al. Transport of Nitrogen Mustard on the Transport-Carrier for Choline in L5178Y Lymphoblasts , 1971, Science.
[11] A. Seligman. Biological Alkylating Agents. Fundamental Chemistry and the Design of Compounds for Selective Toxicity. , 1962 .
[12] F. DeEds,et al. The metabolic fate of rutin and quercetin in the animal body. , 1956, The Journal of biological chemistry.
[13] E. Mackay,et al. The absorption and excretion of rutin and related flavonoid substances. , 1950, Journal of the American Medical Association.
[14] F. Wilcoxon,et al. A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.
[15] K. Boda,et al. Antitumor activity of flavonoids on NK/Ly ascites tumor cells. , 1981, Neoplasma.
[16] R. F. Raffauf,et al. Antineoplastic activity and cytotoxicity of flavones, isoflavones, and flavanones. , 1979, Journal of natural products.
[17] N. Takeichi,et al. Xenogenization of Lymphocytes, Erythroblasts, and Tumor Cells , 1978 .
[18] L. Griffiths,et al. Metabolism of myricetin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. , 1972, The Biochemical journal.
[19] L. Németh,et al. A new mouse ascites tumour to be used as a screening tool. , 1961, Neoplasma.